<DOC>
	<DOC>NCT00621218</DOC>
	<brief_summary>To compare the efficacy and safety of tretinoin gel 0.05% to its vehicle when dosed once or twice daily in female subjects with rosacea.</brief_summary>
	<brief_title>A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Female Age 1865 Diagnosed with classical, centrofacial, erythematotelangiectatic rosacea Male, females less than 18 years Females over 65 years No diagnosed rosacea</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>tretinoin, efficacy, safety, rosacea</keyword>
</DOC>